CIAM
AZN icon

Caitong International Asset Management’s AstraZeneca AZN Stock Holding History

Caitong International Asset Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1
Closed -$197 – 3005
2026
Q1 		$197 Sell
1
-1,193
-100% -$230K ﹤0.01% 1881
2025
Q4 		$219K Buy
1,194
+67
+6% +$11.8K 0.05% 187
2025
Q3 		$173K Buy
1,127
+52
+5% +$7.87K 0.12% 88
2025
Q2 		$150K Buy
1,075
+820
+322% +$115K 0.11% 106
2025
Q1 		$37.4K Buy
+255
New +$36.9K 0.03% 589

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Caitong International Asset Management's AZN Position: Q2 2026 in Review

Caitong International Asset Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1 share — an estimated $197 sold.

Caitong International Asset Management first reported a position in AZN in Q1 2025 and held it in 5 quarters. The position peaked at $219K in Q4 2025. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Caitong International Asset Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1 AstraZeneca share in Q2 2026, an estimated $197.
  • Caitong International Asset Management first reported a position in AstraZeneca in Q1 2025 and held it in 5 quarters.
  • Caitong International Asset Management's AstraZeneca position peaked at $219K in Q4 2025.
  • 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.